Invitae Announces Partnership for Real-World Data Sharing to Inform Rare Cancer Research
/PRNewswire/ -- Invitae (NYSE: NVTA), a leading medical genetics company, today announced a partnership with AstraZeneca (LSE/STO/Nasdaq: AZN) to use Invitae's...
Source: prnewswire.com